XML 66 R48.htm IDEA: XBRL DOCUMENT v3.23.3
Summary of Significant Accounting Policies (Details Narrative)
12 Months Ended
Aug. 31, 2023
USD ($)
Integer
shares
Aug. 31, 2022
USD ($)
shares
Allowance for uncollectible accounts receivable $ 864,215 $ 992,329
Inventory 1,027,670
Other receivable written off 299,672
Other receivable prinicipal amount 225,924  
Other receivable accrued interest 73,748  
Impairment of long-lived assets 0 0
Impairment of intangible assets 14,083,531
Contract lease term 12 months  
Goodwill impairment charge 1,357,043
Foreign currency translation gain (loss) $ 922,609 $ 431,605
Number of reportable segments | Integer 2  
Common Stock [Member]    
Debt conversion, converted instrument, shares issued | shares 581,715  
Common Stock To Be Issued [Member]    
Debt conversion, converted instrument, shares issued | shares 91,138  
Options/Warrants Outstanding [Member]    
Potentially dilutive common stock options and warrants outstanding, shares | shares 1,777,678 1,060,950
Terragenx Inc [Member]    
Equity method investment, ownership percentage 91.00%  
12858461 Canada Corp [Member]    
Equity method investment, ownership percentage 50.10%  
Novo Healthnet Kemptville Centre Inc [Member]    
Equity method investment, ownership percentage 80.00%  
Novo Earth Therapeutics Inc [Member]    
Equity method investment, ownership percentage 70.00%